#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cryoglobulinaemia Squamous cell carcinoma of the vulva Acute graft versus host disease in intestine Von Willebrand's disease Infantile apnoea Hereditary ataxia Adrenoleukodystrophy Squamous cell carcinoma of head and neck Ovarian epithelial cancer Glomerulonephritis chronic Hepatoblastoma Stevens-Johnson syndrome Heritable pulmonary arterial hypertension Chronic lymphocytic leukaemia refractory Thalassaemia beta More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome – Basic Information Rhabdomyosarcoma – Basic Information Turner’s syndrome – Treatment Erdheim-Chester disease – Life with Disease Adrenogenital syndrome – Treatment Synovial sarcoma metastatic – Diagnostics CADASIL – Trials in Disease Testicular leiomyosarcoma – Diagnostics Noonan syndrome – Life with Disease Hereditary ataxia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avalglucosidase Alfa Glycerol Phenylbutyrate ALXN1920 Ondansetron Isoprenaline Hydrochloride Belantamab Mafodotin Alectinib ANTIMETABOLITES Nitrogen Sacituzumab Tirumotecan Nalbuphine Hydrochloride Human Fibrinogen Meropenem Trihydrate Folinic Acid Vortioxetine Hydrobromide [18F]Mc225 Spiramycin Remestemcel Azd0901 Fluvastatin Sodium More therapies…

    Learn about Your Condition

    Lung cancer metastatic Endometrial adenocarcinoma Lymphocytic lymphoma Ichthyosis Diabetic ketoacidosis Raynaud's phenomenon Malformation venous Thymoma malignant Seizure Spinal muscular atrophy Breast cancer Hypertension Carcinoid syndrome Tardive dyskinesia Cervix carcinoma stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Henri Mondor – 1 rue Gustave Eiffel

Hopital Henri Mondor – 1 rue Gustave Eiffel

51 Av Du Mal De Lattre De Tassigny, Creteil, 94000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Jnj-77242113
    • Mercaptopurine
    • Azathioprine
    Belgium Czechia France Germany Hungary Italy +3

  • Study on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Pembrolizumab
    • Regorafenib
    Belgium France Germany Italy Romania Spain

  • Study Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Chlorambucil
    • Rasburicase
    • Obinutuzumab
    Austria Bulgaria Croatia Denmark Estonia France +5

  • Study on the Effectiveness and Safety of Lenvatinib, Pembrolizumab, and Chemotherapy for Patients with Advanced or Metastatic Gastroesophageal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    Investigated Drugs:
    • Calcium Folinate
    • Calcium Folinate Pentahydrate
    • Capecitabine
    Belgium France Germany Ireland Italy Poland +1

  • Study Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anal squamous cell carcinoma
    Investigated Drugs:
    • Mitomycin
    • Capecitabine
    • Cisplatin
    France

  • Study on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatic cancer
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Ipilimumab
    France

  • Study of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Gns561
    • Atezolizumab
    • Bevacizumab
    France

  • Study on the Long-Term Safety and Effectiveness of Minzasolmin and Iodine Ioflupane (123I) in Patients with Parkinson’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Ioflupane (123I)
    • Minzasolmin
    France Germany Italy The Netherlands Poland Spain

  • Study Comparing Rituximab and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    • Rituximab
    France

  • Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatitis D
    Investigated Drugs:
    • Bulevirtide
    Austria Belgium France Germany The Netherlands Romania +1
Previous Page
1 … 7 8 9 10 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!